Wen-Chien Cheng

10PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEndocrinology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 05, 2024
Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer.

Yu-Chuan Lin, Mei-Chih Chen, Shi-Wei Huang

|Mar 13, 2024
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors.

Chih-Yen Tu, Te-Chun Hsia, Ying-Chun Lin

|Sep 02, 2021
l-lactic acidosis confers insensitivity to PKC inhibitors by competing for uptake via monocarboxylate transporters.

Khuong T L Nguyen, Jhih-Yi Chiou, You-Chi Liu

|Jun 22, 2021
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs.

Chia-Hung Chen, Bo-Wei Wang, Yu-Chun Hsiao

|Jun 11, 2021
A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease.

Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao

|Jan 15, 2021
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy.

Wen-Chien Cheng, Te-Chun Hsia, Chih-Yen Tu

Pageof 2

Frequent Collaborators

4 joint publications

Wei-Chien Huang

3 joint publications

Chia-Hung Chen

3 joint publications

Te-Chun Hsia

2 joint publications

Mien-Chie Hung